Pat Furlong

1.2k total citations
17 papers, 243 citations indexed

About

Pat Furlong is a scholar working on Molecular Biology, Biomedical Engineering and Physiology. According to data from OpenAlex, Pat Furlong has authored 17 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Physiology. Recurrent topics in Pat Furlong's work include Muscle Physiology and Disorders (11 papers), Biomedical Ethics and Regulation (4 papers) and Biomedical and Engineering Education (3 papers). Pat Furlong is often cited by papers focused on Muscle Physiology and Disorders (11 papers), Biomedical Ethics and Regulation (4 papers) and Biomedical and Engineering Education (3 papers). Pat Furlong collaborates with scholars based in United States, United Kingdom and Netherlands. Pat Furlong's co-authors include Holly L. Peay, Craig M. McDonald, Bettina Meiser, Ann Martin, Ryan Fischer, Aad Tibben, Elizabeth Vroom, Richard T. Wang, Kathryn M. Porter and Annemieke Aartsma‐Rus and has published in prestigious journals such as Nature Biotechnology, Molecular Therapy and Muscle & Nerve.

In The Last Decade

Pat Furlong

16 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pat Furlong United States 10 128 50 45 41 39 17 243
Ryan Fischer United States 11 138 1.1× 58 1.2× 60 1.3× 96 2.3× 46 1.2× 27 351
Filippo Buccella Italy 5 160 1.3× 20 0.4× 53 1.2× 8 0.2× 32 0.8× 9 222
Uswa Shahzad Canada 10 140 1.1× 21 0.4× 62 1.4× 12 0.3× 7 0.2× 15 342
Crystal M. Proud United States 9 170 1.3× 20 0.4× 124 2.8× 8 0.2× 58 1.5× 25 281
Marcus Vinícius Magno Gonçalves Brazil 13 93 0.7× 33 0.7× 14 0.3× 12 0.3× 12 0.3× 54 469
Brendan J. McCullough United States 10 51 0.4× 12 0.2× 36 0.8× 13 0.3× 17 0.4× 16 370
Andrea Kelemen Hungary 11 137 1.1× 36 0.7× 7 0.2× 9 0.2× 11 0.3× 25 388
Kun Xuan China 8 140 1.1× 30 0.6× 38 0.8× 3 0.1× 12 0.3× 17 330
K Stephens United States 7 79 0.6× 37 0.7× 17 0.4× 4 0.1× 52 1.3× 133 296
Emma S. James United States 9 110 0.9× 60 1.2× 55 1.2× 5 0.1× 52 1.3× 13 285

Countries citing papers authored by Pat Furlong

Since Specialization
Citations

This map shows the geographic impact of Pat Furlong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pat Furlong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pat Furlong more than expected).

Fields of papers citing papers by Pat Furlong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pat Furlong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pat Furlong. The network helps show where Pat Furlong may publish in the future.

Co-authorship network of co-authors of Pat Furlong

This figure shows the co-authorship network connecting the top 25 collaborators of Pat Furlong. A scholar is included among the top collaborators of Pat Furlong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pat Furlong. Pat Furlong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ward, Leanne M., David R. Weber, Sze Choong Wong, et al.. (2025). A Parent Project Muscular Dystrophy-sponsored International Workshop Report on Endocrine and Bone Issues in Patients with Duchenne Muscular Dystrophy: An Ever-changing Landscape. Journal of Neuromuscular Diseases. 12(1). 116–133.
2.
McDonald, Craig M., Richard S. Finkel, Ryan Fischer, et al.. (2024). Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease. Journal of Neuromuscular Diseases. 11(2). 499–523. 5 indexed citations
3.
4.
5.
Caplan, Arthur L., et al.. (2021). Gene therapy companies have an ethical obligation to develop expanded access policies. Molecular Therapy. 29(4). 1367–1369. 13 indexed citations
6.
Marbán, Linda, Craig M. McDonald, Michelle Eagle, et al.. (2020). LATE BREAKING NEWS E-POSTER PRESENTATION. Neuromuscular Disorders. 30. S168–S169. 4 indexed citations
7.
Battaglia, Manuela, Pat Furlong, Nico Wulffraat, & Felicitas Bellutti Enders. (2019). Improving the Translational Medicine Process: Moving Patients From “End-Users” to “Engaged Collaborators”. Frontiers in Medicine. 6. 110–110. 3 indexed citations
8.
Furlong, Pat, et al.. (2019). Delays in diagnosis of Duchenne muscular dystrophy: An evaluation of genotypic and sociodemographic factors. Muscle & Nerve. 61(1). 36–43. 18 indexed citations
9.
Kearns, Lisa S., et al.. (2019). What compassionate use means for gene therapies. Nature Biotechnology. 37(4). 352–355. 15 indexed citations
10.
Kakkis, Emil, Gerald F. Cox, Mark P. Hayes, et al.. (2015). Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints. Orphanet Journal of Rare Diseases. 10(1). 16–16. 36 indexed citations
11.
Kinnett, Kathi, et al.. (2015). Imperatives for DUCHENNE MD: a Simplified Guide to Comprehensive Care for Duchenne Muscular Dystrophy. PLoS Currents. 7. 15 indexed citations
12.
Peay, Holly L., et al.. (2015). Mothers’ psychological adaptation to Duchenne/Becker muscular dystrophy. European Journal of Human Genetics. 24(5). 633–637. 32 indexed citations
13.
Furlong, Pat, John F. P. Bridges, Lawrence Charnas, et al.. (2015). How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration. Orphanet Journal of Rare Diseases. 10(1). 82–82. 35 indexed citations
14.
Kinnett, Kathi, E H Wagner, Larry D. Cripe, et al.. (2015). Addressing discrepancies in care with the certified Duchenne care center program. Neuromuscular Disorders. 25. S199–S200. 1 indexed citations
15.
Lynn, Stephen, Annemieke Aartsma‐Rus, Kate Bushby, et al.. (2014). Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy. Neuromuscular Disorders. 25(1). 96–105. 31 indexed citations
16.
Kalman, Lisa V., Jay Leonard, Norman P. Gerry, et al.. (2011). Quality Assurance for Duchenne and Becker Muscular Dystrophy Genetic Testing. Journal of Molecular Diagnostics. 13(2). 167–174. 18 indexed citations
17.
McInerney, Joseph D., et al.. (2010). Trust It or Trash It? A Tool for Evaluating the Quality of Genetic Information. Genetic Testing and Molecular Biomarkers. 14(6). 743–748. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan Fischer Breakdown of academic impact, for papers by Filippo Buccella Breakdown of academic impact, for papers by Uswa Shahzad Breakdown of academic impact, for papers by Crystal M. Proud Breakdown of academic impact, for papers by Marcus Vinícius Magno Gonçalves Breakdown of academic impact, for papers by Brendan J. McCullough Breakdown of academic impact, for papers by Andrea Kelemen Breakdown of academic impact, for papers by Kun Xuan Breakdown of academic impact, for papers by K Stephens Breakdown of academic impact, for papers by Emma S. James
Rankless by CCL
2026